(Q42662066)
Statements
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival (English)
Raymond L Benza
Robyn J Barst
Adaani Frost
Reda E Girgis
Kristin B Highland
Carol M Black
David B Badesch
Lewis Rubin
Thomas R Fleming